Cargando…
Development of a 2-(2-Hydroxyphenyl)-1H-benzimidazole-Based Fluorescence Sensor Targeting Boronic Acids for Versatile Application in Boron Neutron Capture Therapy
SIMPLE SUMMARY: In boron neutron capture therapy (BNCT), the amount and localization of boron-10 atoms in tumor tissues directly determine the therapeutic effect. This study developed a novel fluorescence sensor, BITQ, to analyze boronic acid agents used for BNCT. Mixing BITQ and a representative (1...
Autores principales: | Kondo, Naoya, Takada, Shinya, Hagimori, Masayori, Temma, Takashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046934/ https://www.ncbi.nlm.nih.gov/pubmed/36980747 http://dx.doi.org/10.3390/cancers15061862 |
Ejemplares similares
-
A Red-Emitting Fluorescence Sensor for Detecting Boronic Acid-Containing Agents in Cells
por: Kondo, Naoya, et al.
Publicado: (2022) -
Evaluation of 3-Borono-l-Phenylalanine as a Water-Soluble Boron Neutron Capture Therapy Agent
por: Kondo, Naoya, et al.
Publicado: (2022) -
Boron-peptide conjugates with angiopep-2 for boron neutron capture therapy
por: Xiang, Jing, et al.
Publicado: (2023) -
Theranostics in Boron Neutron Capture Therapy
por: Sauerwein, Wolfgang A. G., et al.
Publicado: (2021) -
Boron Neutron Capture Therapy for Malignant Brain Tumors
por: MIYATAKE, Shin-Ichi, et al.
Publicado: (2016)